Related Experiment Video
Updated: Jun 16, 2026
08:29
Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling
Published on: August 1, 2016
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility.
Sabine Huke1, Björn C Knollmann
1Division of Clinical Pharmacology, Vanderbilt University, Nashville, TN 37232-0575, USA.
Journal of Molecular and Cellular Cardiology
|January 26, 2010
Summary
Increased myofilament calcium sensitivity is linked to cardiac arrhythmias in cardiomyopathies. This review explores how this sensitivity impacts heart function and promotes arrhythmias through various cellular mechanisms.
Area of Science:
- Cardiology
- Molecular Biology
- Physiology
Background:
- Increased myofilament calcium sensitivity is a hallmark of various cardiomyopathies.
- This heightened sensitivity is independently associated with an increased risk of cardiac arrhythmias.
Purpose of the Study:
- To review and discuss the molecular and cellular mechanisms by which increased myofilament calcium sensitivity contributes to cardiac arrhythmias.
- To explore the downstream effects of elevated myofilament calcium sensitivity on cardiac excitation and arrhythmogenesis.
Main Methods:
- Literature review of existing studies on myofilament calcium sensitivity and arrhythmias.
- Discussion of proposed molecular and cellular pathways.
- Analysis of downstream effects on calcium handling, metabolism, and mechanical stress.
Main Results:
- Increased myofilament calcium sensitivity alters cardiac excitation-contraction coupling.
- Downstream effects include impaired calcium buffering, compromised energy metabolism, and increased mechanical stretch.
- These alterations collectively contribute to the generation of cardiac arrhythmias.
Conclusions:
- Elevated myofilament calcium sensitivity is a significant factor in the development of cardiac arrhythmias in cardiomyopathies.
- Understanding these mechanisms is crucial for developing targeted therapies.
- Further research into the interplay of calcium sensitivity, cellular function, and arrhythmogenesis is warranted.
More Related Videos
Related Concept Videos
01:28Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:21G-Protein Gated Ion Channels
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Sensory organs,...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...